BEVERLY, MA and TORONTO, ON–(Marketwired – Jul 16, 2014) – Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced that it has received notice that the China Food and Drug Administration (CFDA) has approved the Company’s cutting edge LYKOS^® for sale to clinical markets in China. Concurrent to this, the Company is pleased to announce it has received a Notification to Grant Patent Right for Invention covering the Modular Laser Assembly that is at the heart of its LYKOS system.

Source: http://www.marketwired.com/mw/release.do?id=1930168&sourceType=3

This entry was posted on Wednesday, July 16th, 2014 at 7:20 am and is filed under Press Release. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.